{"symbol":"BSX","fiscalQuarter":"Q2-2018","reportDate":"2018-07-25","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2018","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 2.23%","keyNumbers":[{"metric":"EPS","actual":"$0.41","expected":"N/A","surprise":"+16.39%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They noted ongoing investments in innovation and market expansion."],"summary":"Overall, management expressed confidence in the company's growth trajectory. They emphasized their commitment to enhancing product offerings."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.23% increase in stock price. The strong EPS performance indicates effective cost management and possibly robust demand for their products. However, the lack of revenue figures and guidance leaves some uncertainty about future performance.","metaDescription":"Boston Scientific (BSX) Q2 2018 earnings: EPS beat by 16.39%. Stock up 2.23%. Full breakdown."}}